Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review

  • ID: 1495342
  • SWOT Analysis
  • 54 pages
  • GlobalData
  • Coloplast Ltd.
1 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • C. R. Bard Inc
  • ConvaTec Group Plc
  • Hollister Inc
  • Rochester Medical Ltd.
  • The Procter & Gamble Co
  • MORE
Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advanced foam dressings and hydrocolloid dressings for infected, non-infected and painful wounds; cleansers; moisturizers; skin protectants; anti-fungals; and hand cleansers. It also offers a wide range of disposable products to support endourologic and percutaneous procedures, prostate disorders, laparoscopic procedures, and testicular prosthesis. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers and retailers in Europe, Asia-Pacific and North America. Coloplast is headquartered in Humlebaek, Denmark.

Coloplast AS Key Recent Developments

May 03, 2018: Coloplast delivers 8% organic revenue growth and upgrades full-year growth expectations
Feb 01, 2018: Coloplast delivers solid Q1 interim results and continues to take market share
Dec 07, 2017: The Board of Directors of Coloplast elected its own Chairman and Deputy Chairman
Nov 03, 2017: Coloplast delivers satisfactory full-year results and increases long-term growth ambitions
Aug 16, 2017: Coloplast delivers satisfactory Q3 result

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • C. R. Bard Inc
  • ConvaTec Group Plc
  • Hollister Inc
  • Rochester Medical Ltd.
  • The Procter & Gamble Co
  • MORE
Section 1 - About the Company
  • Coloplast A/S - Key Facts
  • Coloplast A/S - Key Employees
  • Coloplast A/S - Key Employee Biographies
  • Coloplast A/S - Major Products and Services
  • Coloplast A/S - History
  • Coloplast A/S - Company Statement
  • Coloplast A/S - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Coloplast A/S - Business Description
  • Business Segment: Chronic Care
  • Overview
  • Performance
  • Business Segment: Urology Care
  • Overview
  • Performance
  • Business Segment: Wound & Skin Care
  • Overview
  • Performance
  • Geographical Segment: Emerging Markets
  • Target Markets
  • Geographical Segment: European Markets
  • Target Markets
  • Target Markets
  • Geographical Segment: Other developed markets
  • Target Markets
  • R&D Overview
  • Coloplast A/S - Corporate Strategy
  • Coloplast A/S - SWOT Analysis
  • SWOT Analysis - Overview
  • Coloplast A/S - Strengths
  • Coloplast A/S - Weaknesses
  • Coloplast A/S - Opportunities
  • Coloplast A/S - Threats
  • Coloplast A/S - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Coloplast A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Coloplast A/S, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Coloplast A/S, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 03, 2018: Coloplast delivers 8% organic revenue growth and upgrades full-year growth expectations
  • Feb 01, 2018: Coloplast delivers solid Q1 interim results and continues to take market share
  • Dec 07, 2017: The Board of Directors of Coloplast elected its own Chairman and Deputy Chairman
  • Nov 03, 2017: Coloplast delivers satisfactory full-year results and increases long-term growth ambitions
  • Aug 16, 2017: Encompass Home Health Awards Ostomy Care Agreement to Coloplast
  • Aug 16, 2017: Coloplast delivers satisfactory Q3 result
  • May 03, 2017: Coloplast delivers satisfactory Q2 result
  • Apr 03, 2017: Coloplast wins Red Dot design award for high quality design
  • Feb 22, 2017: Coloplast Awarded Wound and Skin Care Products agreement with Premier
  • Feb 02, 2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Coloplast A/S, Key Facts
  • Coloplast A/S, Key Employees
  • Coloplast A/S, Key Employee Biographies
  • Coloplast A/S, Major Products and Services
  • Coloplast A/S, History
  • Coloplast A/S, Other Locations
  • Coloplast A/S, Subsidiaries
  • Coloplast A/S, Key Competitors
  • Coloplast A/S, Ratios based on current share price
  • Coloplast A/S, Annual Ratios
  • Coloplast A/S, Annual Ratios
  • Coloplast A/S, Annual Ratios
  • Coloplast A/S, Interim Ratios
  • Coloplast A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Coloplast A/S, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Coloplast A/S, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Coloplast A/S, Performance Chart (2013 - 2017)
  • Coloplast A/S, Ratio Charts
  • Coloplast A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Coloplast A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • The Procter & Gamble Co
  • Rochester Medical Ltd.
  • Hollister Inc
  • ConvaTec Group Plc
  • C. R. Bard Inc
  • B. Braun Melsungen AG
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll